Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We describe the implantation of 4 epidural stimulation paddles directly above the dura mater over both the left and right frontopolar and dorsolateral prefrontal cortices. Placement was verified using postoperative computed tomography (CT) coregistered with presurgical magnetic resonance imaging (MRI).

Abstract

We describe the targeting, surgical technique, intraoperative testing, and postoperative programming strategy for the invasive neuromodulatory technique termed epidural prefrontal cortical stimulation (EpCS). While EpCS has been explored by several groups, the unique approach described here involves surgical placement of four epidural cortical stimulation paddles - two over the bilateral dorsolateral prefrontal cortex (DLPFC) and two over the frontopolar cortex (FPC). The safety and efficacy of this technique for treatment-resistant depression has been described previously by the authors. 5 subjects were implanted with EpCS (3 with major depression, 2 with bipolar affective disorder I, depressive type) and their depressive symptoms were followed for five years. Application of chronic electrical stimulation (10-15mA) across all four of these paddles produced a durable antidepressant response for 3 of 5 subjects at the five-year follow-up. This manuscript discusses the unique intraoperative testing strategy as well as the programming approaches employed in this study. We aim to give guidance into improving the effect size of this novel form of stimulation.

Introduction

Nonpharmacologic brain stimulation therapies have emerged as potentially promising treatments for a variety of illnesses, including depression1. Depression is a disabling psychiatric disorder of melancholia that not only affects an individual's daily life and social functioning2, but is a leading cause of premature mortality and disability worldwide3. Large clinical trials have shown that pharmacologic interventions have limited success in treating depression4. Roughly 41% of patients fail to respond to two adequate trials of pharmacologic treatment, which is the defini....

Protocol

These experiments were conducted at the Medical University of South Carolina (MUSC) in compliance with an Investigational Device Exemption issued to Ziad Nahas and later transferred to Edward Baron Short under US Food and Drug Administration (FDA) guidance. The MUSC Institutional Review Board approved the protocol.

1. Participants

  1. For each subject, conduct comprehensive assessment including detailed neuropsychological testing at baseline and repeatedly after implantation. Fuse the .......

Representative Results

Sample Characteristics: A total of 6 patients were enrolled in this trial. 1 withdrew prior to EpCS implantation. A total of 5 patients (3 female, mean age=44.2 years, SD=9.4 years) received EpCS implantation and completed the trial through the 5-year follow-up period. Sample characteristics are summarized in Table 1. A total of 3 subjects had a diagnosis of MDD while the 2 remaining participants had a diagnosis of bipolar affective disorder I, depressive.......

Discussion

In this manuscript, we describe the method of EpCS of the bilateral DLPFC and FPC for the treatment of TRD. This first iteration of bilateral EpCS of DLPFC and FPC resulted in a remission rate of 60% at five year follow-up, and 80% shortly thereafter, in a group of severely depressed patients33. Despite years of chronic stimulation of the FPC and DLPFC, no changes were noted in neuropsychiatric measures of cognition and this method was generally well tolerated by all participants.

Acknowledgements

The Stanford Clinical and Translational Science Award to Spectrum (NIH UL1 TR 001085) (NRW) and the Brain & Behavior Research Foundation (NRW).

....

Materials

NameCompanyCatalog NumberComments
3T MRI ScannerSiemens
Computer workstation
Imaging softwareUniversity of South CarolineMRIcro; http://www.sph.sc.edu/comd/rorden/mricro.html
Electrocardiography
Pulse oximetry
End-tidal CO2
Non-invasive blood pressure monitoring
Fentanyl (50-250 micrograms)
Propofol infusion (25-100 micrograms/kg/min
2% lidocaine with epinephrine (2ccs)
Equal mixture of 1% lidocaine with epinephrine 1:100,000 and bupivacaine 0.5% (5ccs)
Skull clamp with surgical pinsIntegraTM, Plainsboro, New JerseyMayfield
Neuronavigation systemBrainLab, Westchester, IllinoisVectorVision
Paddle leads with extensionsMedtronic Inc., Minneapolis, MinnesotaResume
Pulse generater with 2 channelsMedtronic Inc., Minneapolis, MinnesotaSynergy
NeurostimulatorMedtronic Inc., Minneapolis, MinnesotaActiva PC/RC
Standard aesculap power-drill
Generic 4mm spherical diamond drill bit
Plates and microscrewsStryker, Kalamazoo, MichiganLeibinger "Dog-bone" style
Bacitracin solution
Vancomycin power
Gelfoam
2-0 vicryl sutures
3-0 nylon sutures
Sterile dressing materals
Endotracheal anesthesiaAs dictated by patient's history and anesthesiologist's preference
3-0 vicryl sutures
4-0 nylon sutures
High resolution spiral CT scan without contrast
Opiate analgesics
Programmer wandMedtronic Inc., Minneapolis, MinnesotaN'Vision Clinician Programmer

References

  1. Williams, N. R., et al. Interventional Psychiatry: Why Now?. J Clin Psychiatry. 75 (8), 895-897 (2014).
  2. Williams, N., Simpson, A. N., Simpson, K., Nahas, Z. Relapse rates with long-term antidepressant drug therapy: a meta-analysis.

Explore More Articles

Deep brain stimulationtreatment resistant depressionepidural cortical stimulationepidural prefrontal cortical stimulationdorsolateral prefrontal cortexbrain stimulationinterventional psychiatry

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved